Back |
home / stock / abcl / abcl message board
Subject | By | Source | When |
---|---|---|---|
Great timing on that! | AliasUser1 | investorshub | 05/20/2021 7:28:26 PM |
Been going down and down. Bottom perhaps. | kzivann | investorshub | 05/03/2021 8:14:54 PM |
Ready to buy more if we get a | AliasUser1 | investorshub | 04/28/2021 6:34:14 PM |
Room to run up ahead of 5/13 earnings. $ABCL | AliasUser1 | investorshub | 04/26/2021 6:08:53 PM |
Thinking the chart is turning around. Long term | AliasUser1 | investorshub | 04/21/2021 11:21:24 PM |
$ABCL could be big. Backed-by Thiel Gates DARPA. | AliasUser1 | investorshub | 04/18/2021 4:26:40 AM |
znewcar1: ABCL 27% v3,2M c33.96 f269M H36.78 got S@23.2 yet morning gap Ngo | znewcar1 | investorshangout | 03/31/2021 8:46:33 PM |
P3 program finally Abcellera in the public eye | StockRoomBully | investorshub | 12/11/2020 4:20:57 PM |
Thoughts... | New$tockguy | investorshub | 12/11/2020 3:16:17 PM |
First. | JJ34 | investorshub | 12/11/2020 3:06:12 PM |
News, Short Squeeze, Breakout and More Instantly...
AbCellera Biologics Inc. Company Name:
ABCL Stock Symbol:
NASDAQ Market:
AbCellera Biologics Inc. Website:
AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. A live audio webcast of the earnings conference may be accessed through a link t...
2024-06-13 05:40:00 ET Discovering new drugs can be a lucrative endeavor, but things aren't working out lately for AbCellera Biologics (NASDAQ: ABCL) . Shares of this unusual biotech stock are down by about 57% from the high water mark they set last summer. The steep losses migh...
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m. Pacific Time (3:20 p.m. Eastern Time). A live audio webcast of the presentation may be accessed throug...